Clinical_Trial_Regulatory_Philippines_Credevo

The Philippines is a country with a large population and a wide network of hospitals, medical centers, and healthcare professionals, making it a fertile platform for conducting clinical trials. In clinical trials, the Philippines ranks number three in Southeast countries (US NIH) and ranks number eight worldwide (European Medicines Agency reports). Clinical trial statistics in […]

Read More →
pancreatitis_clinical_trial_feasibility_credevo

Pancreatitis, inflammation of the pancreas, is the leading cause of GI-related hospitalizations in the USA and many other countries, with a medical condition requiring emergent care. The yearly incidence of Acute Pancreatitis in the United States and western countries is approximately 70-80 new cases per 100,000 population and has increased over the last decade. In […]

Read More →
Clinical_Trial_Regulatory_sites_Australia_Credevo

Australia has the world’s best researchers and health professionals, a world-class research infrastructure, and high standards for clinical trial conduct, which leads to quality, increased speed, and high confidence in the results. Note: This article was last updated in Oct 2024. They have quality research facilities, an efficient ethical and regulatory framework, a diverse participant […]

Read More →

Malaysia is one of the world’s most popular countries for coastal tourism, known for its culinary sensations, beautiful beaches, idyllic islands, and national parks. Conducting clinical trials in Malaysia offers a diverse patient population, well-established healthcare infrastructure, favorable regulatory environment, and cost-effective research opportunities. Note: This article was updated in May, 2023 Malaysia owns a large […]

Read More →
acute_myeloid_leukemia_clinical_trial_feasibility_Credevo

Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood that interfere with normal blood cells. It’s sometimes called acute myelocytic, myelogenous, or granulocytic leukemia. Causes of AML The causes of AML remain largely […]

Read More →
Clinical trial approval process in Vietnam Credevo

Vietnam, known for its tourism destination, is also a destination for clinical trials and research. With a sizeable population of 85 million, Vietnam offers a vast pool of participants, healthcare professionals, and strong doctor-patient relationships, which result in a greater retention rate. Clinical Trials in Vietnam In the last few years, Vietnam has been a […]

Read More →

Epidermolysis bullosa (EB) is a rare group of genetic disorders that cause the skin to be very fragile and to blister easily. It is a rare disease, and the condition was brought to public attention in 2004, in the UK through the Channel 4 documentary. It appears in many kinds of forms, and these forms are […]

Read More →
clinical_trial_regulatory_sites_india_credevo

A country with a large pool of patients, highly skilled Investigators, and supportive regulations to promote clinical research is a desired destination for any organization for clinical trials. India has a lot more to offer besides these advantages, enabling you to enjoy the timely completion of clinical trials and cost benefits. (India offers a 35 […]

Read More →
Feasibility Questionnaire: What Should You Know About and Include In It?

This article was last updated on 17/11/2025 Clinical trial feasibility is a process that evaluates the possibility of conducting a clinical trial in a specific region or at selected medical centers/sites. It answers key questions: Can we finish on time? Can enough patients be recruited? Is it financially and operationally feasible? This is an integral […]

Read More →
Clinical trials in the United States

The United States is the region that conducts most clinical trials in the world and is the flag bearer for most clinical research studies requires considering many factors and areas. Starting with some salient points on Clinical trials in the United States. In the first part of this series of articles on clinical trials in […]

Read More →